Table 6.

Demographic and clinical characteristic of patients infected by SARS-COV-2.

Case No	Age (year)	Gender	Smoker	Job	Comorbidity	Type of mastocytosis	Suspicious contact	Biologic agent	Treatment for mastocytosis	COVID-19 PCR	Lung Involvement	Symptoms of COVID-19	Stay at hospital	Stay at ICU	Treatment of COVID-19	Drug Reaction to anti-COVID-19 agents	Drug reaction in history
1	37	F	No	Nurse	Absent	ISM	Yes	Absent	Famotidine, Fexofenadine	Positive	Positive	Myalgia and diarrhea	No	No	HCQ + AZ + FP + EP	No	No
2	69	F	No	Retired	Absent	ISM	Yes	Omalizumab	Famotidine, Fexofenadine	Positive	Positive	Fever, cough, myalgia	No	No	HCQ + FP + EP	No	No
3	30	F	Yes	Fashion designer	Absent	ISM	Unknown	Absent	Famotidine, Fexofenadine	Positive	Negative	Fever, sore throat, myalgia	No	No	HCQ + AZ	No	No
4	19	F	Yes	Student	Absent	ISM	Yes	Absent	Famtoidine, Fexofenadine	Positive	Negative	Anosmia, headache, myalgia	No	No	FP	No	No

AZ, Azithromycin; EP, Enoxaparin; F, Female; FP, Favipravir; HCQ, Hydroxychloroquine; HT, Hypertension; ISM, Indolent systemic mastocytosis; M, Male.